Chlordiazepoxide
Chlordiazepoxide is indicated for the short-term (2–4 weeks) treatment of anxiety that is severe and disabling or subjecting the person to unacceptable distress. Reference standards of Chlordiazepoxide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => N-Nitrosochlordiazepoxide
[catalogue_number] => PA 03 0401001
[category_ids] => ,162,82,78,76,75,70,165,
[chemical_name] =>
[weight] => 328.76
[form] => C16H13ClN4O2
[cas] => 51715-17-4
[pslug] => 51715-17-4-n-nitrosochlordiazepoxide-pa030401001
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
N-Nitrosochlordiazepoxide
Catalogue No.:PA 03 0401001
Molecular Formula : C16H13ClN4O2
Molecular Weight : 328.76